Brian Claggett is a Heart Failure & Transplant affiliated with Brigham and Women's Hospital.
Brian Claggett's published research covers Heart Failure with Preserved Ejection Fraction, SGLT2 Inhibitors in Heart Failure, Angiotensin-Neprilysin Inhibition Therapy, Meta-Analysis of Cardiovascular Clinical Trials, and Survival Analysis in Heart Failure Studies. These are the areas where Synapse's enriched corpus most frequently indexes their work.
Brian Claggett is an Associate Scientist in the Division of Cardiovascular Medicine at Brigham and Women's Hospital and an Assistant Professor at Harvard Medical School. He serves as chief statistician for the Cardiac Imaging Core Laboratory and Clinical Trials Endpoints Center at Brigham and Women's Hospital. He has research collaborations with Gentofte Hospital and the University of Copenhagen in the field of heart failure.
Held affiliations with Brigham and Women's Hospital (2010-2025); Harvard University (2010-2025); Asan Medical Center (2024); Aarhus University Hospital (2024).
Across their career Synapse has indexed 1,000 publications, 41,701 citations, h-index 96. Enriched entries for each paper include structured clinical evidence (PICO), methodology classification with level of evidence, and guideline-recommendation linkage where applicable.
Training: PhD at Harvard T.H. Chan School of Public Health (2012); MS at University of Georgia (2007); BS at University of Georgia (2007).
For the full publication history and per-paper clinical evidence enrichment, see this page on Synapse.
Deterministic synthesis from Synapse's enriched records — 212 words.
